IL131811A0 - Antitussive compositions - Google Patents

Antitussive compositions

Info

Publication number
IL131811A0
IL131811A0 IL13181198A IL13181198A IL131811A0 IL 131811 A0 IL131811 A0 IL 131811A0 IL 13181198 A IL13181198 A IL 13181198A IL 13181198 A IL13181198 A IL 13181198A IL 131811 A0 IL131811 A0 IL 131811A0
Authority
IL
Israel
Prior art keywords
theobromine
admixture
additives
salts
active ingredients
Prior art date
Application number
IL13181198A
Other languages
English (en)
Original Assignee
Korbonits Dezso
Aranyi Peter
Jelinek Istvan
Mikus Endre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korbonits Dezso, Aranyi Peter, Jelinek Istvan, Mikus Endre filed Critical Korbonits Dezso
Publication of IL131811A0 publication Critical patent/IL131811A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
IL13181198A 1997-03-26 1998-03-20 Antitussive compositions IL131811A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700654A HUP9700654A2 (hu) 1997-03-26 1997-03-26 Teobromin tartalmú köhögéscsillapító készítmények
PCT/HU1998/000027 WO1998042322A2 (en) 1997-03-26 1998-03-20 Antitussive compositions

Publications (1)

Publication Number Publication Date
IL131811A0 true IL131811A0 (en) 2001-03-19

Family

ID=89994918

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13181198A IL131811A0 (en) 1997-03-26 1998-03-20 Antitussive compositions
IL131811A IL131811A (en) 1997-03-26 1999-09-09 A mixture of cough medicines containing thiobromine

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL131811A IL131811A (en) 1997-03-26 1999-09-09 A mixture of cough medicines containing thiobromine

Country Status (23)

Country Link
US (1) US6348470B1 (bg)
EP (1) EP0969843B1 (bg)
JP (1) JP4450872B2 (bg)
KR (1) KR100420370B1 (bg)
CN (1) CN1251039A (bg)
AT (1) ATE218868T1 (bg)
AU (1) AU6741498A (bg)
BG (1) BG103780A (bg)
BR (1) BR9809057A (bg)
CA (1) CA2284774C (bg)
CZ (1) CZ295801B6 (bg)
DE (1) DE69805983T2 (bg)
DK (1) DK0969843T3 (bg)
EA (1) EA001971B1 (bg)
EE (1) EE9900428A (bg)
ES (1) ES2178188T3 (bg)
HU (1) HUP9700654A2 (bg)
IL (2) IL131811A0 (bg)
NO (1) NO994640L (bg)
PL (1) PL190899B1 (bg)
PT (1) PT969843E (bg)
SK (1) SK285023B6 (bg)
WO (1) WO1998042322A2 (bg)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030032484A (ko) * 2001-10-18 2003-04-26 롯데제과주식회사 발암 억제효능을 갖는 데오브로민
JP2004018512A (ja) * 2002-06-20 2004-01-22 Morinaga & Co Ltd 冷え性改善用組成物および冷え性改善用組成物の製造のためのカカオ豆加工物の使用
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물
US7914828B2 (en) * 2008-10-17 2011-03-29 Levine Brian M Combination herbal product to benefit respiratory tract
US20150005325A1 (en) * 2009-06-16 2015-01-01 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
GB0921805D0 (en) 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
GB201014391D0 (en) * 2010-08-27 2010-10-13 Biocopea Ltd Drug composition and its use in therapy
GB0919889D0 (en) 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB0919893D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB0921803D0 (en) 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
US20150216869A1 (en) * 2009-06-16 2015-08-06 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) * 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
AU2015201845B2 (en) * 2009-11-13 2015-11-05 Infirst Healthcare Limited Drug combination with theobromine and its use in therapy
US8361519B2 (en) 2010-11-18 2013-01-29 Aadvantics Pharmaceuticals, Inc. Combination herbal product to benefit respiratory tract in people exposed to smoke
NL1040474C2 (en) 2013-10-31 2015-05-04 Veramed B V Nasal compositions stimulating ciliary activity.
ES2552706B1 (es) * 2014-05-29 2016-09-13 Universitat De Les Illes Balears La teobromina y sus derivados para el tratamiento o prevenciónde la litiasis renal
KR20160126217A (ko) 2015-04-23 2016-11-02 주식회사 진명 에프 엠 씨 용기 투입장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1113122B (it) * 1978-04-06 1986-01-20 Abc Ist Biolog Chem Spa Composizione farmaceutica ad attivita' antibrocospastica e antitosse
FR2531339A1 (fr) 1982-08-04 1984-02-10 Dietlin Francois Nouveau procede d'obtention de formes pharmaceutiques a liberation programmee
HU197574B (en) * 1986-10-09 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for production of derivatives of 3,7-dihydro-3-methil-7-//1,2,4-oxadiasole/-3-il/alkylenil/-1h-purin-2,6-dion and medical compositions containing these substances
GB2201591B (en) 1987-03-02 1990-11-14 Ricerfarma Srl Analgesic antipyretic and anti-inflammatory compositions.
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
US5560913A (en) * 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5641512A (en) 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
EP0841947A1 (en) 1995-07-28 1998-05-20 The Procter & Gamble Company Compositions containing analgesics and antihistamines and methods for treating respiratory disorders

Also Published As

Publication number Publication date
DE69805983T2 (de) 2003-01-30
EA199900876A1 (ru) 2000-04-24
IL131811A (en) 2006-06-11
PT969843E (pt) 2002-10-31
EP0969843A2 (en) 2000-01-12
US6348470B1 (en) 2002-02-19
SK127399A3 (en) 2000-09-12
CA2284774C (en) 2005-12-06
EP0969843B1 (en) 2002-06-12
DE69805983D1 (de) 2002-07-18
PL190899B1 (pl) 2006-02-28
BR9809057A (pt) 2000-08-01
SK285023B6 (sk) 2006-04-06
KR20010005642A (ko) 2001-01-15
HU9700654D0 (en) 1997-05-28
KR100420370B1 (ko) 2004-03-03
AU6741498A (en) 1998-10-20
NO994640D0 (no) 1999-09-24
JP4450872B2 (ja) 2010-04-14
CZ339199A3 (cs) 2000-04-12
PL335979A1 (en) 2000-06-05
WO1998042322A3 (en) 1998-12-17
CN1251039A (zh) 2000-04-19
ATE218868T1 (de) 2002-06-15
HUP9700654A2 (hu) 1999-09-28
CA2284774A1 (en) 1998-10-01
BG103780A (bg) 2001-04-30
JP2001518928A (ja) 2001-10-16
NO994640L (no) 1999-09-24
DK0969843T3 (da) 2002-10-07
WO1998042322A2 (en) 1998-10-01
EA001971B1 (ru) 2001-10-22
CZ295801B6 (cs) 2005-11-16
ES2178188T3 (es) 2002-12-16
EE9900428A (et) 2000-04-17

Similar Documents

Publication Publication Date Title
PL335979A1 (en) Antitussive compositions
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
WO1999064059A3 (en) Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
EP1023901A4 (en) MEDICINES FOR HEPATITIS C AND THE USE THEREOF
IL126175A0 (en) Method or treating heart failure with endothelin antagonists and pharmaceutical compositions containing the same
EP0799618A3 (en) Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer
GB1474424A (en) Pharmaceutical composition for treating diabetic ketoacidosis
IL145722A0 (en) Pharmaceutical composition comprising growth hormone and interferon
EP0443028A4 (en) NON-INJECTABLE CARCINOSTATIC AGENT FOR PREVENTING INFLAMMATION BY 5-FLUORURACIL AND METHOD FOR TREATING CANCER.
DE69102174D1 (de) Iontophoresezusammensetzung zur Erhöhung der Hautkonzentration aktiver Wirkstoffe.
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
AU1564500A (en) Method for obtaining and using a combination of a purine and a nitrogen monoxidedonor for preventing or treating sexual dysfunction
AU8900498A (en) Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
DE69736955D1 (de) Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed